君圣泰医药,迎来重磅首席医疗官

医药之梯
Feb 03

2月2日,君圣泰医药-B(02511)发布公告,任命Filip Surmont博士为首席医学官,旨在强化公司在心肾代谢系统疾病(CKM)领域的布局。资料显示,Filip Surmont 博士拥有比利时根特大学医学博士学位及运动医学硕士学位,在医疗与制药行业拥有超过30年的丰富经验,职业生涯早期,他曾为奥运级运动员提供医疗服务,他曾任职于惠氏、辉瑞、阿斯利康等跨国药企,在心血管、代谢和肾脏疾病领域是...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10